GRI Bio, Inc. Common Stock (GRI) is a publicly traded Healthcare sector company. As of August 14, 2026, GRI trades at $1.81 with a market cap of $3.45M and a P/E ratio of -0.01. GRI moved +2.20% today. Year to date, GRI is -77.42%; over the trailing twelve months it is -95.14%. Its 52-week range spans $1.36 to $437.92. Analyst consensus is buy with an average price target of $21.00. Rallies surfaces GRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for GRI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.81 |
| Market Cap | $3.45M |
| P/E Ratio | -0.01 |
| EPS | $-121.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $437.92 |
| 52-Week Low | $1.36 |
| Volume | 2.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.96M |
| Gross Margin | 0.00% |
2 analysts cover GRI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.00.